Claussnitzer, M. et al. A brief history of human disease genetics. Nature 577, 179–189 (2020).
Google Scholar
Dorling, L. et al. Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Med. 14, 51 (2022).
Google Scholar
Breast Cancer Association Consortium et al. Breast Cancer Risk Genes—association analysis in more than 113,000 women. N. Engl. J. Med. 384, 428–439 (2021).
Google Scholar
Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47–54 (2016).
Google Scholar
Cooper, G. M. & Shendure, J. Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet. 12, 628–640 (2011).
Google Scholar
Tabet, D., Parikh, V., Mali, P., Roth, F. P. & Claussnitzer, M. Scalable functional assays for the interpretation of human genetic variation. Annu. Rev. Genet. 56, 19.1–19.25 (2022).
Google Scholar
Starita, L. M. et al. Variant interpretation: functional assays to the rescue. Am. J. Hum. Genet. 101, 315–325 (2017).
Google Scholar
Weile, J. & Roth, F. P. Multiplexed assays of variant effects contribute to a growing genotype-phenotype atlas. Hum. Genet. 137, 665–678 (2018).
Google Scholar
Fowler, D. M. & Fields, S. Deep mutational scanning: a new style of protein science. Nat. Methods 11, 801–807 (2014).
Google Scholar
Findlay, G. M. et al. Accurate classification of BRCA1 variants with saturation genome editing. Nature 562, 217–222 (2018).
Google Scholar
Findlay, G. M., Boyle, E. A., Hause, R. J., Klein, J. C. & Shendure, J. Saturation editing of genomic regions by multiplex homology-directed repair. Nature 513, 120–123 (2014).
Google Scholar
Li, H. et al. Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells. Nat. Biomed. Eng. 8, 165–176 (2024).
Google Scholar
Hanna, R. et al. Massively parallel assessment of human variants with base editor screens. Cell 184, 1064–1080.e20 (2020).
Google Scholar
Cuella-Martin, R. et al. Functional interrogation of DNA damage response variants with base editing screens. Cell 184, 1081–1097.e19 (2021).
Google Scholar
Huang, C., Li, G., Wu, J., Liang, J. & Wang, X. Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction. Genome Biol. 22, 80 (2021).
Google Scholar
Kweon, J. et al. A CRISPR-based base-editing screen for the functional assessment of BRCA1 variants. Oncogene 39, 30–35 (2020).
Google Scholar
Kim, Y. et al. High-throughput functional evaluation of human cancer-associated mutations using base editors. Nat. Biotechnol. 40, 874–884 (2022).
Google Scholar
Erwood, S. et al. Saturation variant interpretation using CRISPR prime editing. Nat. Biotechnol. 40, 885–895 (2022).
Google Scholar
Monteiro, A. N. et al. Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation. J. Med. Genet. 57, 509–518 (2020).
Google Scholar
Parsons, M. T. et al. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification. Hum. Mutat. 40, 1557–1578 (2019).
Google Scholar
Guidugli, L. et al. Assessment of the clinical relevance of BRCA2 missense variants by functional and computational approaches. Am. J. Hum. Genet. 102, 233–248 (2018).
Google Scholar
Richardson, M. E. et al. Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance. Am. J. Hum. Genet. 108, 458–468 (2021).
Google Scholar
Biswas, K. et al. A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays. NPJ Genom. Med. 5, 52 (2020).
Google Scholar
Ikegami, M. et al. High-throughput functional evaluation of BRCA2 variants of unknown significance. Nat. Commun. 11, 2573 (2020).
Google Scholar
Biswas, K. et al. Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs. Cell Rep. Methods 3, 100628 (2023).
Google Scholar
Mishra, A. P. et al. BRCA2–DSS1 interaction is dispensable for RAD51 recruitment at replication-induced and meiotic DNA double strand breaks. Nat. Commun. 13, 1751 (2022).
Google Scholar
Mishra, A. P. et al. Characterization of BRCA2 R3052Q variant in mice supports its functional impact as a low-risk variant. Cell Death Dis. 14, 753 (2023).
Google Scholar
Hartford, S. A. et al. Interaction with PALB2 is essential for maintenance of genomic integrity by BRCA2. PLoS Genet. 12, e1006236 (2016).
Google Scholar
Roy, R., Chun, J. & Powell, S. N. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat. Rev. Cancer 12, 68–78 (2011).
Google Scholar
Kuznetsov, S. G., Liu, P. & Sharan, S. K. Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2. Nat. Med. 14, 875–881 (2008).
Google Scholar
Sharan, S. K. BRCA2 deficiency in mice leads to meiotic impairment and infertility. Development 131, 131–142 (2003).
Google Scholar
Sahu, S. et al. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants. PLoS Genet. 19, e1010940 (2023).
Google Scholar
Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980–D985 (2014).
Google Scholar
Cline, M. S. et al. BRCA challenge: BRCA exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 14, e1007752 (2018).
Google Scholar
Lord, C. J. & Ashworth, A. PARP inhibitors: synthetic lethality in the clinic. Science 355, 1152–1158 (2017).
Google Scholar
Clark, K. A. et al. Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions. Am. J. Hum. Genet. 109, 1153–1174 (2022).
Google Scholar
Pejaver, V. et al. Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3/BP4 criteria. Am. J. Hum. Genet. 109, 2163–2177 (2022).
Google Scholar
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
Google Scholar
Brnich, S. E. et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019).
Google Scholar
Tavtigian, S. V., Harrison, S. M., Boucher, K. M. & Biesecker, L. G. Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelines. Hum. Mutat. 41, 1734–1737 (2020).
Google Scholar
Sahu, S. et al. Protocol for the saturation and multiplexing of genetic variants using CRISPR–Cas9. STAR Protoc. 4, 102702 (2023).
Google Scholar
Easton, D. F. et al. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am. J. Hum. Genet. 81, 873–883 (2007).
Google Scholar
Sirisena, N. et al. Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay. Breast Cancer Res. 22, 43 (2020).
Google Scholar
Biswas, K. et al. A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay. Blood 118, 2430–2442 (2011).
Google Scholar
Arnaudi, M. et al. MAVISp: multi-layered assessment of variants by structure for proteins. Preprint at bioRxiv https://doi.org/10.1101/2022.10.22.513328 (2023).
Yang, H. et al. BRCA2 function in DNA binding and recombination from a BRCA2–DSS1–ssDNA structure. Science 297, 1837–1848 (2002).
Google Scholar
Li, H. et al. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genet Med. 24, 119–129 (2022).
Google Scholar
Spurdle, A. B. et al. Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA report. J. Med. Genet. 56, 347–357 (2019).
Google Scholar
Hu, C. et al. Functional analysis and clinical classification of 462 germline BRCA2 missense variants affecting the DNA binding domain. Am. J. Hum. Genet. 111, 584–593 (2024).
Google Scholar
Shimelis, H. et al. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 77, 2789–2799 (2017).
Google Scholar
Huang, H. et al. Functional evaluation and clinical classification of BRCA2 variants. Nature https://doi.org/10.1038/s41586-024-08388-8 (2024).
Ran, F. A. et al. Genome engineering using the CRISPR–Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
Google Scholar
Walker, L. C. et al. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: recommendations from the ClinGen SVI Splicing Subgroup. Am. J. Hum. Genet. 110, 1046–1067 (2023).
Google Scholar
Drost, M. et al. A functional assay-based procedure to classify mismatch repair gene variants in Lynch syndrome. Genet. Med. 21, 1486–1496 (2019).
Google Scholar
Sorrentino, E. et al. Integration of VarSome API in an existing bioinformatic pipeline for automated ACMG interpretation of clinical variants. Eur. Rev. Med. Pharmacol. Sci. 25, 1–6 (2021).
Google Scholar
Kopanos, C. et al. VarSome: the human genomic variant search engine. Bioinformatics 35, 1978–1980 (2019).
Google Scholar
Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941–D947 (2019).
Google Scholar
de Bruijn, I. et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 83, 3861–3867 (2023).
Google Scholar
Tiberti, M. et al. MutateX: an automated pipeline for in silico saturation mutagenesis of protein structures and structural ensembles. Brief. Bioinformatics 23, bbac074 (2022).
Google Scholar
Sora, V. et al. RosettaDDGPrediction for high-throughput mutational scans: from stability to binding. Protein Sci. 32, e4527 (2023).
Google Scholar
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Google Scholar
Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).
Google Scholar
Frazer, J. et al. Disease variant prediction with deep generative models of evolutionary data. Nature 599, 91–95 (2021).
Google Scholar
Rentzsch, P., Schubach, M., Shendure, J. & Kircher, M. CADD-Splice-improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 13, 31 (2021).
Google Scholar
Feng, B.-J. PERCH: a unified framework for disease gene prioritization. Hum. Mutat. 38, 243–251 (2017).
Google Scholar
Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877–885 (2016).
Google Scholar
Tavtigian, S. V., Deffenbaugh, A. M., Yin, L., Judkins, T., Scholl, T., Samollow, P. B., de Silva, D., Zharkikh, A. & Thomas, A. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J. Med. Genet. 43, 295–305 (2005).
Google Scholar
